APA (7th ed.) Citation

Desterke, C., Balducci, E., Fund, X., Borie, C., Bennaceur-Griscelli, A., & Turhan, A. G. (2018). A Novel Metabolic Transcriptome Identified in Myelodysplastic Syndromes (MDS) Correlates with OMS Classification and Poor Prognosis. Blood, 132(Supplement 1), 5495. https://doi.org/10.1182/blood-2018-99-110678

Chicago Style (17th ed.) Citation

Desterke, Christophe, Estelle Balducci, Xavier Fund, Claire Borie, Annelise Bennaceur-Griscelli, and Ali G. Turhan. "A Novel Metabolic Transcriptome Identified in Myelodysplastic Syndromes (MDS) Correlates with OMS Classification and Poor Prognosis." Blood 132, no. Supplement 1 (2018): 5495. https://doi.org/10.1182/blood-2018-99-110678.

MLA (9th ed.) Citation

Desterke, Christophe, et al. "A Novel Metabolic Transcriptome Identified in Myelodysplastic Syndromes (MDS) Correlates with OMS Classification and Poor Prognosis." Blood, vol. 132, no. Supplement 1, 2018, p. 5495, https://doi.org/10.1182/blood-2018-99-110678.